Menarini has announced 2 M&A deals since 2005, with the deals being the acquisition of Invida Holdings and Silicon Biosystems.
Abstracted from: Partnering Deals and Alliances with Menarini
Menarini is involved in M&A activity for growth similar to its peers in the list of top pharmaceutical/biotechnology companies. Menarini sought growth in the oncology therapy area with the purchase of Silicon Biosystems.
With the acquisition of Invida Holdings, Menarini strategically expanded their presence in the Asian market.
The following figure shows the level of Menarini M&A deal announcements since 2005.
Source: Current Agreements, 2013
Menarini has signed 2 M&A deals since 2005. Companies acquired include:
View the full details of the deals at Current Agreements (subscription required)
Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Menarini
Available reports from Current Partnering
Report: Partnering Deals and Alliances with Menarini
Report: Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics
Available resources for deal coverage for Menarini
Read: more on Menarini company profile, recent partnering, M&A and financing news and articles
Report: Practical Guide to Finding Partners
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk